The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of T-DM1 alone versus T-DM1 and metronomic temozolomide in secondary prevention of HER2-positive breast cancer brain metastases following stereotactic radiosurgery.
 
Alexandra Dos Santos Zimmer
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
DeeDee Kay Smart
No Relationships to Disclose
 
Mark R. Gilbert
No Relationships to Disclose
 
Terri Armstrong
No Relationships to Disclose
 
Eric Burton
No Relationships to Disclose
 
Nicole D. Houston
No Relationships to Disclose
 
Nadia Biassou
No Relationships to Disclose
 
Brunilde Gril
No Relationships to Disclose
 
Priscilla Kaliopi Brastianos
Honoraria - Angiochem; Genentech; Merck
Consulting or Advisory Role - Angiochem; ElevateBio; Genentech/Roche; Lilly; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Lilly; Merck; Pfizer
 
Scott L Carter
No Relationships to Disclose
 
David Lyden
No Relationships to Disclose
 
Stanley Lipkowitz
No Relationships to Disclose
 
Patricia Schriver Steeg
No Relationships to Disclose